BriaCell Therapeutics Corp. (BCTX) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 West Vancouver, BC, 加拿大. 现任CEO为 William V. Williams.
BCTX 拥有 IPO日期为 2012-03-14, 16 名全职员工, 在 NASDAQ Capital Marke, 市值为 $8.7M.
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
